Evidence map›Paper›PMID 42000797›Full record

ArticleScientific reports2026

Fabrication of nitrofurantoin-loaded chitosan-silver nanoparticles for the treatment of urinary tract infections.

G N Ningaraju, S Nanjundaswamy, Mohammed Ghazwani, Yahya Alhamhoom, Riyaz Ali M Osmani, Mano Govindharaj, Fawzi Banat, C S Karthik

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

G N NingarajuDepartment of Chemistry, SJCE, JSS Science and Technology University, Mysuru, Karnataka, 570 006, India.
S NanjundaswamyDepartment of Chemistry, SJCE, JSS Science and Technology University, Mysuru, Karnataka, 570 006, India.
Mohammed GhazwaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha-62223, Saudi Arabia.
Yahya AlhamhoomDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha-62223, Saudi Arabia.
Riyaz Ali M OsmaniDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha-62223, Saudi Arabia.
Mano GovindharajFood Security and Technology Center, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates.
Fawzi BanatDepartment of Chemical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.
C S KarthikDepartment of Chemistry, SJCE, JSS Science and Technology University, Mysuru, Karnataka, 570 006, India. csk@jssstuniv.in.

Funding

Deanship of Research and Graduate Studies at King Khalid University RGP2/514/46
6 · The paper itself

Abstract

Urinary tract infections (UTIs), particularly catheter-associated UTIs (CAUTIs), pose significant global health challenges. In this study, chitosan-silver nanoparticles loaded with nitrofurantoin (NFT*C@AgNPs) were utilized to combat CAUTIs, highlighting their strong antimicrobial potential. The physicochemical characterization was performed using UV-Vis, FT-IR, XRD, Zeta Potential, FE-SEM, TGA, and ICP-OES. Drug release studies revealed a linear release profile (R

Indexed as

Anti-Bacterial AgentsChitosanMetal NanoparticlesNitrofurantoinSilverUrinary Tract InfectionsBiofilmsDrug LiberationEscherichia coliHumansMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsChitosanNitrofurantoinSilverCatheterChitosanNitrofurantoinSilver nanoparticlesUrinary tract infections

Identifiers

PMID42000797
PMCPMC13249853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.